This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Dorthe Marcher: Innovator in Enzyme Modification
Introduction
Dorthe Marcher is a notable inventor based in Farum, Denmark. She has made significant contributions to the field of biotechnology, particularly in enzyme modification. Her work focuses on improving the stability of enzymes, which has important implications for various industrial applications.
Latest Patents
Dorthe Marcher holds a patent for the "Use of an α-amylase modified to improve oxidation stability." This innovation highlights her expertise in enzyme technology and its potential benefits in enhancing product performance.
Career Highlights
Marcher is currently employed at Novo Nordisk A/S, a leading global healthcare company. Her role involves research and development in the field of biotechnology, where she applies her knowledge to create innovative solutions. With 1 patent to her name, she has established herself as a valuable contributor to her field.
Collaborations
Dorthe has collaborated with esteemed colleagues, including Annette Hanne Toft and Hanne Ho Pedersen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Dorthe Marcher exemplifies the spirit of innovation in biotechnology through her work at Novo Nordisk A/S. Her contributions to enzyme modification are paving the way for advancements in the industry.